More Articles
Cannabidiol (CBD) could potentially play a helpful role in the management of patients with cardiovascular disease (CVD), according to a new report published in Mayo Clinic Proceedings.[1] It is still early, however, and much more…
Stereotaxis, a St. Louis-based medtech company, has received U.S. Food and Drug Administration (FDA) approval for a new robotically navigated magnetic ablation catheter built to perform minimally invasive…
Abbott has received U.S. Food and Drug Administration (FDA) approval for its…
The Heart Rhythm Society (HRS) has announced a new registry for collecting and storing real-time data on patients who undergo pulsed field ablation (PFA) to treat atrial fibrillation (AFib). To minimize…
As the old saying goes: If at first you don’t succeed, try, try again.
Milestone Pharmaceuticals has received U.S. Food and Drug Administration (FDA) approval for etripamil, a new nasal spray for adult…
San Diego-based Vektor Medical has gained an updated clearance from the U.S. Food and Drug Administration (FDA) for its…
Pediatric electrophysiology (EP) is an invaluable part of any healthcare system, using advanced technologies to evaluate and treat young patients for a variety of…
Patients with diabetes face a significantly higher risk of sudden cardiac death (SCD), according to a new study of nearly 7,000 patients published in European Heart Journal.[1]
The relationship was seen in patients with both type 1…
Atraverse Medical, a San Diego-based medtech startup, has received U.S. Food and Drug Administration (FDA) clearance for its Hotwire Transseptal Access System.
The newly cleared system includes the Hotwire…
Cardiology groups share new recommendations for performing safe, effective cardiac ablations in ASCs
Two leading cardiology groups, the Heart Rhythm Society (HRS) and American College of Cardiology (ACC), have published a new scientific statement on how to safely,…
The Centers for Medicare and Medicaid Services (CMS) has finalized new payment policies that will radically change the way cardiac ablation procedures are reimbursed going forward.
The 2026 Hospital…
Boston Scientific announced a collaboration with Epic, the largest U.S. electronic health record (EHR) vendor, to better integrate its cardiac ambulatory monitoring data into Aura, Epic’s specialty diagnostics suite.
…
Medtronic had a strong second quarter, reporting a worldwide revenue of $8.96 billion, and earnings per share (EPS) of $1.36. Both figures exceeded the company’s expectations.
Medtronic’s cardiovascular portfolio helped lead the way…
Hexoskin, a Canadian medtech company, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a new “smart shirt” capable of long-term heart and respiratory monitoring.
The…
For the first time in the United States, drones will be used to quickly deliver automated external defibrillators (AEDs) to bystanders who call 911 for patients in cardiac arrest. The idea is to deliver an AED before police or paramedics arrive…
Boston Scientific and Siemens Healthineers have entered into a strategic partnership to develop improved workflows for Siemens' next-generation AcuNav 4D intracardiac echocardiography (ICE) catheter. ICE has increasingly been used to guide…
Drinking coffee may help patients with atrial fibrillation (AFib) significantly reduce their risk of recurrent AFib episodes, according to new data presented at the American Heart Association’s…
Withings, a French medtech company, has received U.S. Food and Drug Administration (FDA) clearance for…
Heart Rhythm Advocates, the advocacy arm of the Heart Rhythm Society (HRS), will host a virtual town hall meeting Tuesday, Nov. 18, at 7 p.m. ET to…
Black patients have a lower prevalence of atrial fibrillation (AFib) than white adults, but their outcomes and mortality are worse, so earlier identification of those who may be at higher risk for Afib is seen as a key to improve outcomes. New…
New-onset atrial fibrillation (AFib) after coronary artery bypass grafting (CABG) is relatively common, according to new data published in JAMA.[1] However, the AFib burden for these patients is low, especially after 30 days.
The…